Bio-Rad Laboratories, Inc. (NYSE:BIO) Forecasted to Earn Q4 2024 Earnings of $2.77 Per Share
Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) – Analysts at Zacks Research dropped their Q4 2024 EPS estimates for shares of Bio-Rad Laboratories in a research report issued on Monday, October 14th. Zacks Research analyst R. Department now forecasts that the medical research company will earn $2.77 per share for the quarter, down from their […]
15 Oct 11:52 · The Markets Daily